Vortioxetine hydrobromide troban Smiles: C/C(=C(\CCOP(O)(O)=O)/SC(=O)C1C=CC=CC=1)/N(CC1=CN=C(C)N=C1N)C=O

Smiles: C/C(=C(\CCOP(O)(O)=O)/SC(=O)C1C=CC=CC=1)/N(CC1=CN=C(C)N=C1N)C=O

4r)-4-((R)-1-aminoethyl)-N-(pyridin-4-yl)cyclohexanecarboxamide dihydrochloride

JNK phosphorylation and vascular smooth muscle cell proliferation via the induction of heme oxygenase-1

Cystic fibrosis (CF) is a genetic disorder that causes multiorgan morbidity and premature death

42-dodecamethyl-15

Vortioxetine hydrobromide troban Smiles: C/C(=C(\CCOP(O)(O)=O)/SC(=O)C1C=CC=CC=1)/N(CC1=CN=C(C)N=C1N)C=OVortioxetine, also known as Lu AA21004, is an atypical antidepressant, and was approved in 2013 by the U. S. FDA for the treatment of major depressive disorder (MDD) in adults. Vortioxetine is a so called "serotonin modulator and stimulator." It has been shown to possess the following pharmacological actions: Serotonin transporter (SERT) blocker (i. e. serotonin reuptake inhibitor (SRI)) Ki (binding affinity) = 1. 6 nM, IC50 = 5. 4 nM; Norepinephrine